Geoffrey Martha
At a glance: Geoffrey Martha is CEO, Chair at Medtronic (MDT). Their latest SEC Form 4, filed Oct 16, 2026, reported a sale of $4.8M. On file: 0 purchase lines ($0) and 1 sale line ($4.8M).
Disclosed holdings: about $27.9M of MDT stock: 277,866 shares reported on their latest Form 4 (filed Oct 16, 2026), valued at the Nov 19, 2026 close of $100.58. This counts only MDT shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
CEO, Chair at Medtronic plc (MDT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 16SEC | MDTMedtronic plc | Sell Plan | 50,000277,866 held (−15%) | $95.00 | $4.8M | +5.9% |
- Sell
CEO, Chair Geoffrey Martha sold $4.8M of MDT at $95.00 — pre-scheduled 10b5-1 plan sale.
Follow Geoffrey Martha
Get one email when Geoffrey Martha files a new purchase or sale. Free.
At most one email a day about Geoffrey Martha, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.